申请人:Saha Ashis
公开号:US20100317649A1
公开(公告)日:2010-12-16
The present invention relates to compounds that have activity as S1P receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate S1P receptor activity. In certain embodiments, the compounds of the invention relate to aryl oxoimidazolidinyls.
本发明涉及具有S1P受体调节剂活性的化合物,以及使用这些化合物治疗与不适当的S1P受体活性相关的疾病。在某些实施例中,本发明的化合物涉及芳基氧代咪唑啉基。